Published in the journal Proceedings of the National Academy of Sciences, the team, led by Professors Claire Harris and Professor Paul Morgan, showed that when the «homing» agent was injected into mice immediately
after traumatic brain injury, it specifically targeted the injured tissue, serving to inactivate the complement system and reduce inflammation and neuronal
damage.